Stocks Teva Pharmaceutical Industries Ltd

More

  • Following are the day’s biggest winners and losers. Find out why shares of Barrick Gold and Research In Motion popped while Mastercard and Teva Pharma dropped.

  • Stocks finished mixed Tuesday as techs struggled after a downgrade on Intel. Transports rose following news that that Warren Buffett is buying Burlington Northern railroad. Industrials also gained after this week's encouraging manufacturing reports.

  • Stocks tumbled Tuesday, led by techs after an analyst downgrade on Intel. Transports rose following news that Warren Buffett is buying Burlington Northern railroad.

  • With the markets in volatility mode, investors will likely be focusing on the Federal Reserve Tuesday, even though the 2-day Federal Open Market Committee meeting that begins this afternoon won't conclude until Wednesday. 

  • We asked the traders for their favorite stocks to 'buy and hold' for the long-term. After all, good things come to those who wait!

  • Markets rose on Thursday after data showed the economy grew more than expected last quarter and jobless claims fell. How should investors be positioning their portfolios now? Dan Genter, president, CEO and CIO of RNC Genter Capital Management, and Dean Barber, founder and president of Barber Financial Group, shared their market insights.

  • Stocks opened mixed after several earnings reports beat expectations but economic numbers missed their targets. Dan Genter of RNC Genter Capital Management and Alan Gayle of RidgeWorth Capital Management shared their market outlooks.

  • Shares of generic drugmaker Mylan dropped for the third straight session yesterday but drew heavy upside options activity.

  • Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • We know it seems like the Fast Money moves at the speed of light. So we thought you’d appreciate it if we slowed things down a bit.Following you’ll find Fast Money’s Slow Money trades – stocks the traders would buy and hold for the next five years!

    We thought you’d appreciate it if we slowed things down a bit.  Here you’ll find Fast Money’s Slow Money trades – stocks the traders would buy and hold for the next five years!

  • Although Wednesday's market action appears bullish, technical analysts are starting to see a ‘head and shoulders' pattern emerging and that's worrisome.

  • The Dow jumped 150 points off the morning lows. Does this bullish reversal mean you should jump back in?

  • Fortune

    For the first time, Fortune opened its 100 Fastest-Growing Companies list to businesses around the world (if they trade on a U.S. exchange and file quarterly reports)—a change that landed Canada's Research in Motion in the No. 1 spot and two Chinese companies in the top 10.

  • For the first time, Fortune opened its 100 Fastest-Growing Companies list to businesses around the world (if they trade on a U.S. exchange and file quarterly reports)—a change that landed Canada's Research in Motion in the No. 1 spot and two Chinese companies in the top 10.

  • The bulls just can't drive the market beyond its 9-month high. Is a correction coming?

  • Stocks ended slightly lower Tuesday, though the Nasdaq eked out a gain. And Citigroup shares soared.

  • Stocks skidded Tuesday after a report showed consumer confidence is waning amid worries about the job market. It was a struggle all morning as investors juggled another batch of disappointing earnings results against an encouraging report on the housing market.

  • After a huge two week really, is Tuesday's market weakness an early sign of a sharp pull back or nothing more than expected profit taking?

  • So far this quarter, only one S&P healthcare company, Aetna, has missed its consensus EPS estimate.  This week there are over 20 more healthcare companies reporting.  Yesterday after the bell Amgen blew the cover off the ball with a 40% rise in earnings and this morning, Teva Pharmaceuticals beat by three cents per share.

  • Stock futures drifted slightly lower ahead of the open Tuesday as investors waited for the next batch of earnings and key economic data.